Microbial models for drug metabolism.
D000175:Acronine / Q000378:metabolism; D000818:Animals; D001060:Aporphines / Q000378:metabolism; D001419:Bacteria / Q000378:metabolism; D001711:Biotransformation; D002186:Cannabinoids / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D003613:Danazol / Q000378:metabolism; D003630:Daunorubicin / Q000378:metabolism; D004611:Ellipticines / Q000378:metabolism; D005658:Fungi / Q000378:metabolism; D007189:Indans / Q000378:metabolism; D008322:Mammals / Q000378:metabolism; D008954:Models, Biological; D010084:Oxidation-Reduction; D010105:Oxygenases / Q000378:metabolism; D010208:Papaverine / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011453:Prostaglandins / Q000378:metabolism; D013045:Species Specificity; D013148:Spironolactone / Q000378:metabolism; D013844:Thiazoles / Q000378:metabolism; D015003:Yeasts / Q000378:metabolism
D001060:Aporphines; D002186:Cannabinoids; D004611:Ellipticines; D007189:Indans; D004364:Pharmaceutical Preparations; D011453:Prostaglandins; D013844:Thiazoles; D013148:Spironolactone; C100273:fenclozic acid; D003577:Cytochrome P-450 Enzyme System; D010208:Papaverine; D010105:Oxygenases; D003613:Danazol; D000175:Acronine; C059095:clidanac; D003630:Daunorubicin